View in EDS

PO-0987: Gemcitabine-based chemoradiotherapy gets improved with PARP inhibitor in pancreatic cancer cells.

Saved in:
Bibliographic Details
Title: PO-0987: Gemcitabine-based chemoradiotherapy gets improved with PARP inhibitor in pancreatic cancer cells.
Authors: Waissi, W., Burckel, H., Magisson, E., Larderet, G., Noel, G.
Source: Radiotherapy & Oncology. May2017 Supplement 1, Vol. 123, pS545-S545. 1p.
Database: Engineering Source
Be the first to leave a comment!
You must be logged in first